Macrophages and cytokines in the early defence against herpes simplex virus
Open Access
- 3 August 2005
- journal article
- review article
- Published by Springer Nature in Virology Journal
- Vol. 2 (1) , 59
Abstract
Herpes simplex virus (HSV) type 1 and 2 are old viruses, with a history of evolution shared with humans. Thus, it is generally well-adapted viruses, infecting many of us without doing much harm, and with the capacity to hide in our neurons for life. In rare situations, however, the primary infection becomes generalized or involves the brain.Normally, the primary HSV infection is asymptomatic, and a crucial element in the early restriction of virus replication and thus avoidance of symptoms from the infection is the concerted action of different arms of the innate immune response. An early and light struggle inhibiting some HSV replication will spare the host from the real war against huge amounts of virus later in infection. As far as such a war will jeopardize the life of the host, it will be in both interests, including the virus, to settle the conflict amicably. Some important weapons of the unspecific defence and the early strikes and beginning battle during the first days of a HSV infection are discussed in this review.Generally, macrophages are orchestrating a multitude of anti-herpetic actions during the first hours of the attack. In a first wave of responses, cytokines, primarily type I interferons (IFN) and tumour necrosis factor are produced and exert a direct antiviral effect and activate the macrophages themselves. In the next wave, interleukin (IL)-12 together with the above and other cytokines induce production of IFN-γ in mainly NK cells. Many positive feed-back mechanisms and synergistic interactions intensify these systems and give rise to heavy antiviral weapons such as reactive oxygen species and nitric oxide. This results in the generation of an alliance against the viral enemy.However, these heavy weapons have to be controlled to avoid too much harm to the host. By IL-4 and others, these reactions are hampered, but they are still allowed in foci of HSV replication, thus focusing the activity to only relevant sites. So, no hero does it alone. Rather, an alliance of cytokines, macrophages and other cells seems to play a central role. Implications of this for future treatment modalities are shortly considered.Keywords
This publication has 446 references indexed in Scilit:
- Mathematical analysis demonstrates that interferons- and - interact in a multiplicative manner to disrupt herpes simplex virus replicationJournal of Theoretical Biology, 2005
- Cytokines and cytokine receptorsImmunological Reviews, 2004
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Alternative activation of macrophagesNature Reviews Immunology, 2003
- A Prospective Study of New Infections with Herpes Simplex Virus Type 1 and Type 2New England Journal of Medicine, 1999
- The antiviral activity of tumour necrosis factor on herpes simplex virus type 1: role for a butylated hydroxyanisole sensitive factorArchives of Virology, 1995
- Penetration of cells by herpes simplex virus does not require a low pH-dependent endocytic pathwayVirus Research, 1991
- Neural infection in mice after cutaneous inoculation with HSV-1 is under complex host genetic controlVirus Research, 1989
- Use of Routine Viral Cultures at Delivery to Identify Neonates Exposed to Herpes Simplex VirusNew England Journal of Medicine, 1988
- Low Risk of Herpes Simplex Virus Infections in Neonates Exposed to the Virus at the Time of Vaginal Delivery to Mothers with Recurrent Genital Herpes Simplex Virus InfectionsNew England Journal of Medicine, 1987